Skip to content

Unexpected CD4 declines seen on full dose ddI with tenofovir

Regions with fastest growing HIV epidemics have worst rates of MDR-TB says WHO

Tipranavir emergency use programme expands

Women with HIV have reduced bone density, may benefit from regular checks

Tenofovir/FTC once daily tablet ready by 2005

Less HAART use, more unsafe sex, could mean 50% leap in new HIV cases in Aussie gay men

HIV envelope may hold clues to likely treatment response

30% of mother to child HIV infections occur in the womb

Diabetes drug and exercise help reduce heart disease risk and improve body shape in HAART patients